Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/224979
SARC-F as a Screening Tool in Rheumatoid Arthritis: Real-World Burden of Sarcopenia Risk, Sex Differences, and Clinical Correlates
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Background/Objectives: Sarcopenia is now recognized as a frequent and disabling accompaniment of rheumatoid arthritis (RA), although structured screening approaches are still rarely applied in everyday practice. The SARC-F questionnaire offers a simple, validated, patient-reported tool for sarcopenia screening, but its performance in RA remains largely unexplored. We aimed to evaluate the burden of sarcopenia risk, defined by abnormal SARC-F scores (>= 4), and its clinical correlates in RA compared with age- and sex-matched controls. Methods: We conducted an observational case-control study including 275 RA patients (69.5% women) aged >50 years and 300 matched controls. Clinical, laboratory, and patient-reported outcomes were recorded. Sarcopenia risk was assessed using SARC-F (cutoff >= 4). RA patients also underwent grip strength and gait speed testing. Multivariable regression analyses were used to identify independent correlates of abnormal SARC-F results. Results: A SARC-F score >= 4 was observed in 26.9% of RA patients. Compared with controls, the burden was significantly higher in women with RA (34.0% vs. 24.7%, p < 0.05) but not in men (10.7% vs. 15.0%). Within the RA cohort, abnormal SARC-F was independently associated with female sex (OR 3.14, 95% CI 1.24-7.95) and higher RAPID3 scores (OR 1.25, 95% CI 1.18-1.33). More than half of RA patients exhibited low grip strength, with partial overlap with SARC-F findings. Conclusions: The SARC-F questionnaire revealed a notable burden of sarcopenia risk in RA, particularly among women. Combined with simple grip strength testing, it offers a feasible, low-cost approach to case finding, directly applicable in routine rheumatology practice. Incorporating this strategy may enhance recognition and management of sarcopenia in RA.
Subject (English)
Citation
Citation
NOLLA SOLÉ, Joan Miquel, et al. SARC-F as a Screening Tool in Rheumatoid Arthritis: Real-World Burden of Sarcopenia Risk, Sex Differences, and Clinical Correlates. Journal of Clinical Medicine. 2025. Vol. 14, num. 21, pags. 7751. ISSN 2077-0383. [consulted: 15 of June of 2026]. Available at: https://hdl.handle.net/2445/224979